Managing Director Ms. Jennifer Che was invited to speak at the 2nd Annual ICMIS 2025 (CoCHE), where she delivered a presentation titled “IP Strategy as the Cornerstone of Medical Innovation Commercialisation: Lessons from Global Markets”.

In her talk, Jennifer explored the critical role of intellectual property strategy in successfully commercialising medical innovations. Drawing from global market experiences, she shared practical insights on building robust IP portfolios, navigating regulatory challenges, maximising commercial value, and avoiding common pitfalls faced by companies in the medical and biotechnology sectors.

Our Past Events

Recommended Insights

What Microsoft’s Recent Patent Invalidation Case in China Teaches Us About User Interface Patents

29 January 2026
Each year the CNIPA publishes its Top Ten Patent Re-examination and Invalidation Cases for the previous year. These cases are meant to be guiding cases, showcasing exemplary real-world decisions that clarify certain aspects of the law. Today we’ll be sharing about one of the Top 10 Invalidation Cases in 2024 involving Microsoft (China) Co., Ltd. […]

Can I transfer priority rights in China without the consent of other applicants? Insights from the Broad Institute’s CRISPR patent

4 February 2025
The high-profile disputes surrounding an important CRISPR patent belonging to The Broad Institute, MIT and Harvard (hereinafter “the proprietors”) has attracted a lot of attention in recent years, particularly regarding the validity of priority rights that were challenged worldwide. In Europe, the patent was famously revoked by the European Patent Office (hereinafter “EPO”) due to […]

CHINA: How Prohibiting "Illegal" Inventions Runs into Food Safety Law

22 October 2021
Chinese Patent Law has an interesting provision that specifically prohibits patent protection on “illegal” or “immoral” inventions. What does this mean, exactly? According to Article 5.1 of the Chinese Patent Law, “no patent shall be granted for an invention that contravenes any law or social moral or that is detrimental to public interests.” On its […]

New Fee Standards Released for Chinese Patent Applications

6 September 2024
Recently, the Chinese government issued four official notices introducing new fee standards and deduction rules for Chinese patent applications.1 These updates address international applications (PCT applications) and the Chinese national phase applications thereof, as well as patent term adjustment/extension (PTA/PTE). Please find our summary below: PCT application fee deduction rules   Application fee & extra […]
Top crossarrow-right